PALX — Palomino Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- $386.91m
- $367.47m
Annual cashflow statement for Palomino Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.002 | -0.016 | -3.16 |
| Non-Cash Items | -0.014 | 0.014 | 1.9 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.002 | -0.002 | -0.025 |
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Cash from Operating Activities | -0.014 | -0.005 | -1.28 |
| Financing Cash Flow Items | 0.153 | 0 | -0.484 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Cash from Financing Activities | 0.153 | 0 | 9.27 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0.14 | -0.005 | 7.99 |